Neurocrine Biosciences reported $291.8M in Gross Profit on Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 124.93M 14.92M
Adamas Pharmaceuticals ADMS:US 25.32M 3.88M
Alexion Pharmaceuticals ALXN:US $ 1511.1M 71.5M
ALKERMES ALKS:US 244.58M 6.01M
Alnylam Pharmaceuticals ALNY:US $ 154.97M 35.33M
Amgen AMGN:US $ 5097M 208M
Biogen BIIB:US $ 2267.1M 48.2M
Biomarin Pharmaceutical BMRN:US $ 305.2M 69.43M
Exelixis EXEL:US $ 316.55M 53.74M
Gilead Sciences GILD:US $ 6198M 1371M
Gw Pharmaceuticals GWPH:US $ 140.66M 2.86M
Halozyme Therapeutics HALO:US $ 97.24M 16.2M
Intercept Pharmaceuticals ICPT:US $ 92.17M 3.79M
Intra Cellular Therapies ITCI:US $ 20.21M 2.2M
IONIS PHARMACEUT IONS:US $ 130M 7.21M
Nektar Therapeutics NKTR:US $ 19.61M 1.05M
Neurocrine Biosciences NBIX:US $ 291.8M 6M
Pfizer PFE:US $ 14163M 2178M
Regeneron Pharmaceuticals REGN:US $ 2999.6M 1445.2M
Repligen RGEN:US $ 102.72M 1.75M
Rigel Pharmaceuticals RIGL:US $ 21.39M 4.74M
Sarepta Therapeutics SRPT:US $ 165.96M 21.39M
Teva Pharmaceutical TEVA:IT 1.9B 25M
Ultragenyx Pharmaceutical RARE:US $ 77.47M 6.37M
Vertex Pharmaceuticals VRTX:US $ 1747.65M 182.25M
YTE INCY:US $ 778.52M 105.44M
Zogenix ZGNX:US $ 21.32M 3.75M